These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 32458297)
1. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector". Yan Y; Jing S; Feng L; Zhang J; Zeng Z; Li M; Zhao S; Ou J; Lan W; Guan W; Wu X; Wu J; Seto D; Zhang Q Virol Sin; 2021 Jun; 36(3):354-364. PubMed ID: 32458297 [TBL] [Abstract][Full Text] [Related]
2. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55. Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon. Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098 [TBL] [Abstract][Full Text] [Related]
4. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector. Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273 [TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector. Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906 [TBL] [Abstract][Full Text] [Related]
6. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions. Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776 [TBL] [Abstract][Full Text] [Related]
7. Neutralizing epitopes mapping of human adenovirus type 14 hexon. Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections. Panda S; Banik U; Adhikary AK Infect Genet Evol; 2020 Nov; 85():104439. PubMed ID: 32585339 [TBL] [Abstract][Full Text] [Related]
9. A recombinant replication-defective human adenovirus type 3: a vaccine candidate. Li H; Zhou R; Chen J; Tian X; Zhang Q; Zeng Q; Gong S Vaccine; 2009 Jan; 27(1):116-22. PubMed ID: 18977265 [TBL] [Abstract][Full Text] [Related]
10. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice. Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646 [TBL] [Abstract][Full Text] [Related]
11. Rapid Construction of a Replication-Competent Infectious Clone of Human Adenovirus Type 14 by Gibson Assembly. Pan H; Yan Y; Zhang J; Zhao S; Feng L; Ou J; Cao N; Li M; Zhao W; Wan C; Ismail AM; Rajaiya J; Chodosh J; Zhang Q Viruses; 2018 Oct; 10(10):. PubMed ID: 30340336 [TBL] [Abstract][Full Text] [Related]
12. Bivalent vaccine platform based on ca influenza virus vaccine elicits protective immunity against human adenoviruses. Gu H; Gao Y; Zhou S; Sun F; Zhao Z; Wang K; Zhao L; Zhang P; Wang Z; Zhang S; Wang X; Yang P Antiviral Res; 2018 May; 153():78-84. PubMed ID: 29501624 [TBL] [Abstract][Full Text] [Related]
13. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon. Haque E; Banik U; Monowar T; Anthony L; Adhikary AK PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206 [TBL] [Abstract][Full Text] [Related]
14. Development of monoclonal antibodies targeting the conserved fragment of hexon protein to detect different serotypes of human adenovirus. Wu L; Lin Y; Yin J; Yang C; Jiang Y; Zhai L; Wang Y; Zhu L; Wu Q; Zhang B; Wan C; Zhao W; Yang Y; Shen C; Xiao W Microbiol Spectr; 2024 Apr; 12(4):e0181623. PubMed ID: 38385650 [TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon. Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297 [TBL] [Abstract][Full Text] [Related]
16. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3. Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic. Wang X; Kerkmann L; Hetzel M; Windmann S; Trilling M; Zhang W; Ehrhardt A; Bayer W J Virol; 2022 Nov; 96(22):e0113322. PubMed ID: 36342295 [TBL] [Abstract][Full Text] [Related]
18. A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein. Lu J; Wang R; Huang Y; Yu Y; Zhou X; Huang P; Yang Z Virology; 2020 Apr; 543():20-26. PubMed ID: 32056843 [TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56. Duffy MR; Alonso-Padilla J; John L; Chandra N; Khan S; Ballmann MZ; Lipiec A; Heemskerk E; Custers J; Arnberg N; Havenga M; Baker AH; Lemckert A J Gen Virol; 2018 Jan; 99(1):135-147. PubMed ID: 29154744 [TBL] [Abstract][Full Text] [Related]
20. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3. Tian X; Li C; Xue C; Li X; Zhou Z; Zhou R Virus Res; 2013 Nov; 177(2):189-93. PubMed ID: 24018287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]